Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports

• Hauptverfasser: Takefumi Suzuki (VerfasserIn), Nobuko Hara (VerfasserIn), Morichika Osa (VerfasserIn), Kazuhisa Misawa (VerfasserIn), Kazuo Imai (VerfasserIn), Yuji Fujikura (VerfasserIn), Takuya Maeda (VerfasserIn), Wataru Sonehara (VerfasserIn), Akihiko Kawana (VerfasserIn)
• Format: Buch
• Veröffentlicht: BMC, 2017-09-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background The advent of well-tolerated and effective anti-retroviral drugs against human immunodeficiency virus-1 (HIV-1) infection has been a major step forward that has achieved long-term survival in recent years. The number of HIV-1 infected patients who experience difficulty in swallow...